スノーデン株式会社

OPEN

*

Lactic Acid Bacterium LJ88

Lactbacillus johnsonii No.1088(LJ88) is a unique lactic acid bacterium found from human gastric juice, which is beneficial for both "stomach" and "intestine". This is the first lactic acid bacterium raw material beneficial to the stomach.

 Lactic acid bacterium LJ88 was broadcasted on TV in Japan (BS Japan), which can be seen via YouTube.

 

 

 

REFERENCES

  1. 小松靖彦(2017)乳酸菌LJ88 (Lactobacillus johnsonii No.1088):胃と腸のための乳酸菌. New Food Industry 59 (7), 1-8.

  2. Aiba Y, Ishikawa H, Tokunaga M, Komatsu Y. (2017) Anti-Helicobacter pylori activity of non-living, heat-killed form of lactobacilli including Lactobacillus johnsonii No.1088. FEMS Microbiol Lett published online. [PubMed]

  3. 小松靖彦(2017)乳酸菌LJ88殺菌体による胃食道逆流症関連症状の緩和:予備的臨床試験. 食品と開発 52 (4), 65-67.

  4. Komatsu Y, Sasaki T, Ohishi M. (2016) Effect of Heat-Killed Lactobacillus johnsonii No. 1088 on Gastroesophageal Reflux Disease-Related Symptoms: A Pilot Clinical Study. Am J Food Sci Health 2, 176-185. [AIS]

  5. 小松靖彦(2016)胃のためのプロバイオティクス、プレバイオティクス、バイオジェニックス. 食品と開発 51 (9), 71-73.

  6. Komatsu Y, Aiba Y, Nakano Y, Koga Y. (2016) Probiotics, Prebiotics, and Biogenics for the Stomach. In: Prebiotics and Probiotics in Human Nutrition and Health, Rao V and Rao LG eds., InTech, Rijeka, Croatia, p.363-381. (ISBN: 978-953-51-4715-2) [InTech]

  7. 小松靖彦(2015) 新規乳酸菌Lactobacillus jonsonii No.1088: 耐 酸性、抗菌活性、抗ガストリン活性、 プロバイオティクスシンポジウム '15(三井プラザホール、東京).

  8. Aiba Y, Nakano Y, Koga Y, Takahashi K, Komatsu Y. (2015) A highly acid resistant novel strain of Lactobacillus johnsonii No.1088 has anti-bacterial activity, including that against Helcobacter pylori, and inhibits gastrin-mediated acid production in mice. MicrobiologyOpen 4, 465-474. [PubMed]

  9. Takahashi H, Nakano Y, Matsuoka T, Kumaki N, Asami Y, Koga Y. (2011) Role of indigenous lactobacilli in gastrin-mediated acid production in the mouse stomach, Appl Environ Microbiol. 77, 6964-6971. [PubMed]

  10. 中野泰博(2011) Toll-like receptor 2シグナルは胃ガストリン産生細胞の分化を制御する、プロバイオティクスシンポジウム '11(三井プラザホール、東京).

  11. Nakano Y, Koga Y. (2011) Induction of Hypercholesterolemia and liver steatosis by Clostridium Innocuum. International Scientific Conference on Probiotics and Prebiotics. (Kosice, Slovakia).

  12. 相場勇志(2010) Lactobacillus johnsonii No. 1088のコレステロール抑制効果、プロバイオティクスシンポジウム '10(三井プラザホール、東京).

PATENTS

《JP4457364》
《JP5075254》
《US 9243300 B2》
《KR101061143》
《KR101451188》